NeurAxis, Inc. (NRXS) Stock Analysis & Investment Frameworks
NeurAxis, Inc. (NRXS) stock analysis on Invetso. Review NeurAxis, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
NeurAxis, Inc. Company Overview
- Exchange: New York Stock Exchange Arca
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
NeurAxis, Inc. Key Financial Metrics
- Market Cap: $93.12M
- Revenue: $3.57M
- ROE: -173.28%
- ROIC: -109.52%
- Dividend Yield: N/A
About NeurAxis, Inc.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
NeurAxis, Inc. Investment Frameworks
Invetso analyzes NeurAxis, Inc. (NRXS) across the following frameworks:
- NeurAxis, Inc. 10Y Growth Potential
- NeurAxis, Inc. Scenario Analysis
- NeurAxis, Inc. Risks & Opportunities
- NeurAxis, Inc. Economic Moat
- NeurAxis, Inc. Business Model
- NeurAxis, Inc. Management
- NeurAxis, Inc. SWOT Analysis
- NeurAxis, Inc. Porter's 5 Forces
- NeurAxis, Inc. PESTLE Analysis
- NeurAxis, Inc. ESG Analysis